{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T05:07:32Z","timestamp":1793250452786,"version":"4.5.0"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Proton pump inhibitors (PPI) are widely prescribed medications. Proton pump inhibitors exposure may be associated with lower trabecular bone score (TBS), but has not shown a consistent effect on BMD. We hypothesized that abdominal obesity, which is associated with both gastroesophageal disease and PPI use, could confound the relationship between PPI use and TBS. We assessed the effect of PPI use on TBS (primary measurement) and BMD (secondary measurements) before and after adjustment for sagittal abdominal diameter (SAD), a DXA-derived measure of abdominal soft-tissue thickness. The study population comprised 60\u2009930 individuals (90.3% women, mean age 65.7\u00a0yr) that included 11\u2009340 (18.6%) with PPI use in the preceding 12 mo. PPI exposure was categorized from medication persistence ratio (MPR) as non-use (referent), minimal (MPR 0.01-0.25), mild (MPR 0.26-0.5), moderate (MPR 0.51-0.75), and high use (MPR 0.76-1). When logistic regression models were minimally adjusted for age, sex, and scanner, increasing PPI use versus non-use was associated with progressively increasing odds ratios (ORs) for TBS in the lowest tertile (minimal 1.11 [95% CI 1.02-1.22], mild 1.18 [1.04-1.34], moderate 1.34 [1.17-1.53], high 1.41 [1.31-1.52]) but inversely with osteoporotic BMD (minimal 0.97 [0.89-1.06], mild 0.85 [0.75-0.97], moderate 0.82 [0.72-0.94]), and high 0.76 [0.70-0.82]). Sagittal abdominal diameter was greater in PPI users than non-users. After further adjustment for SAD, PPI use was not associated with lower TBS or BMD. Similar patterns were seen in men and women, and for longer durations of PPI use. Among 4742 with a second DXA (mean interval 3.4\u00a0yr), PPI use was not associated with more rapid TBS or BMD loss compared to non-users. In conclusion, PPI use is associated with greater SAD, an indicator of abdominal obesity. SAD and other clinical variables have a confounding effect on TBS and BMD measurements. When fully adjusted, PPI exposure did not significantly decrease TBS or BMD.<\/jats:p>","DOI":"10.1093\/jbmr\/zjaf072","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T08:20:25Z","timestamp":1747210825000},"page":"965-972","source":"Crossref","is-referenced-by-count":4,"title":["Proton pump inhibitor exposure, trabecular bone score, and BMD: a registry-based cohort study"],"prefix":"10.1093","volume":"40","author":[{"given":"Fatima","family":"Zarzour","sequence":"first","affiliation":[{"name":"Department of Medicine, University of Manitoba , Winnipeg, MB , R2H 2A6,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9329-0750","authenticated-orcid":false,"given":"John T","family":"Schousboe","sequence":"additional","affiliation":[{"name":"Park Nicollet Clinic and HealthPartners Institute, HealthPartners , Minneapolis, MN 55416 ,","place":["United States"]},{"name":"Division of Health Policy and Management, University of Minnesota , Minneapolis, MN 55455 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9905-461X","authenticated-orcid":false,"given":"Neil","family":"Binkley","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Wisconsin , Madison, WI 53707 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1826-5958","authenticated-orcid":false,"given":"Didier","family":"Hans","sequence":"additional","affiliation":[{"name":"Bone and Joint Department, Lausanne University Hospital , Lausanne ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1056-1691","authenticated-orcid":false,"given":"William D","family":"Leslie","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Manitoba , Winnipeg, MB , R2H 2A6,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,5,14]]},"reference":[{"issue":"2","key":"2025073008263727300_ref1","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1111\/bcpt.13023","article-title":"Side effects of long-term proton pump inhibitor use: a review","volume":"123","author":"Haastrup","year":"2018","journal-title":"Basic Clini Pharmacol Toxicol"},{"issue":"4","key":"2025073008263727300_ref2","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1503\/cmaj.071330","article-title":"Use of proton pump inhibitors and risk of osteoporosis-related fractures","volume":"179","author":"Targownik","year":"2008","journal-title":"CMAJ"},{"key":"2025073008263727300_ref3","article-title":"Prescription Drug Use among Adults Aged 40\u201379 in the United States and Canada","volume-title":"NCHS Data Brief","author":"Hales"},{"issue":"3","key":"2025073008263727300_ref4","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1172\/JCI111254","article-title":"An evaluation of the importance of gastric acid secretion in the absorption of dietary calcium","volume":"73","author":"Bo-Linn","year":"1984","journal-title":"J Clin Invest"},{"issue":"3","key":"2025073008263727300_ref5","doi-asserted-by":"publisher","first-page":"141","DOI":"10.11005\/jbm.2018.25.3.141","article-title":"Proton-pump inhibitor use and fracture risk: an updated systematic review and meta-analysis","volume":"25","author":"Nassar","year":"2018","journal-title":"J Bone Metab"},{"key":"2025073008263727300_ref6","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.lfs.2018.12.058","article-title":"Proton pump inhibitors therapy and risk of bone diseases: an update meta-analysis","volume":"218","author":"Liu","year":"2019","journal-title":"Life Sci"},{"issue":"6","key":"2025073008263727300_ref7","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.amjmed.2011.01.007","article-title":"Proton pump inhibitors and risk of fractures: a meta-analysis of 11 international studies","volume":"124","author":"Elaine","year":"2011","journal-title":"Am J Med"},{"key":"2025073008263727300_ref8","doi-asserted-by":"publisher","first-page":"100732","DOI":"10.1016\/j.bonr.2020.100732","article-title":"Effect of proton pump inhibitors on bone mineral density: a systematic review and meta-analysis of observational studies","volume":"13","author":"Aleraij","year":"2020","journal-title":"Bone Rep"},{"issue":"1","key":"2025073008263727300_ref9","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/ajg.2016.481","article-title":"Long-term proton pump inhibitor use is not associated with changes in bone strength and structure","volume":"112","author":"Targownik","year":"2017","journal-title":"Am J Gastroentrol"},{"key":"2025073008263727300_ref10","doi-asserted-by":"publisher","first-page":"117066","DOI":"10.1016\/j.bone.2024.117066","article-title":"PPI use is not associated with bone microarchitecture and strength assessed with HR-pQCT after three-years follow-up in patients visiting the fracture liaison service","volume":"182","author":"Schene","year":"2024","journal-title":"Bone"},{"key":"2025073008263727300_ref11","doi-asserted-by":"publisher","first-page":"116668","DOI":"10.1016\/j.bone.2022.116668","article-title":"Bone microstructure in proton pump inhibitor users","volume":"168","author":"Kondapalli","year":"2023","journal-title":"Bone"},{"issue":"2","key":"2025073008263727300_ref12","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.jocd.2018.06.008","article-title":"Lower trabecular bone score is associated with the use of proton pump inhibitors","volume":"22","author":"Shin","year":"2019","journal-title":"J Clin Densitom"},{"key":"2025073008263727300_ref13","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae598","article-title":"Sex-specific association of chronic proton pump inhibitor use with reduced bone density and quality","volume":"110","author":"Bioletto","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2025073008263727300_ref14","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1007\/s00198-023-06817-4","article-title":"Update on the clinical use of trabecular bone score (TBS) in the management of osteoporosis: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), and the International Osteoporosis Foundation (IOF) under the auspices of WHO Collaborating Center for Epidemiology of Musculoskeletal Health and Aging","volume":"34","author":"Shevroja","year":"2023","journal-title":"Osteoporos Int"},{"issue":"1","key":"2025073008263727300_ref15","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.gtc.2009.12.002","article-title":"Gastroesophageal reflux disease and obesity","volume":"39","author":"Anand","year":"2010","journal-title":"Gastroenterol Clin N Am"},{"issue":"2","key":"2025073008263727300_ref16","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.gtc.2023.03.008","article-title":"The effect of obesity on gastrointestinal disease","volume":"52","author":"Shay","year":"2023","journal-title":"Gastroenterol Clin N Am"},{"issue":"7","key":"2025073008263727300_ref17","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1093\/jbmr\/zjae073","article-title":"Effect of abdominal tissue thickness on trabecular bone score and fracture risk in adults with diabetes: the Manitoba BMD registry","volume":"39","author":"Leslie","year":"2024","journal-title":"J Bone Miner Res"},{"issue":"4","key":"2025073008263727300_ref18","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.jocd.2019.08.001","article-title":"Estimating waist and hip circumference from routine clinical DXA","volume":"23","author":"Leslie","year":"2020","journal-title":"J Clin Densitom"},{"issue":"4","key":"2025073008263727300_ref19","doi-asserted-by":"publisher","DOI":"10.1093\/jbmrpl\/ziaf020","article-title":"Opportunistic measurement of sagittal abdominal diameter with bone densitometry predicts death and cardiovascular events","volume":"9","author":"Leslie","year":"2025","journal-title":"JBMR Plus"},{"issue":"3","key":"2025073008263727300_ref20","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1385\/JCD:6:3:275","article-title":"Establishing a regional bone density program: lessons from the Manitoba experience","volume":"6","author":"Leslie","year":"2003","journal-title":"J Clin Densitom"},{"issue":"1","key":"2025073008263727300_ref21","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jocd.2023.01.001","article-title":"Fracture prediction from trabecular bone score is unaffected by anti-resorptive treatment: a registry-based cohort study","volume":"26","author":"Leslie","year":"2023","journal-title":"J Clin Densitom"},{"issue":"4","key":"2025073008263727300_ref22","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/jbmr.4774","article-title":"Contributions of clinical and technical factors to longitudinal change in trabecular bone score and bone density: a registry-based individual-level analysis","volume":"38","author":"Leslie","year":"2023","journal-title":"J Bone Miner Res"},{"issue":"2","key":"2025073008263727300_ref23","doi-asserted-by":"publisher","first-page":"101483","DOI":"10.1016\/j.jocd.2024.101483","article-title":"Estimating lumbar spine least significant change for fewer than four vertebrae: the Manitoba BMD registry","volume":"27","author":"Rosen","year":"2024","journal-title":"J Clin Densitom"},{"issue":"4","key":"2025073008263727300_ref24","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.jocd.2015.03.001","article-title":"Spine-hip thickness difference measured by dual-energy X-ray absorptiometry is associated with diabetes mellitus in women and men","volume":"18","author":"Schacter","year":"2015","journal-title":"J Clin Densitom"},{"issue":"11","key":"2025073008263727300_ref25","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1345\/aph.18117","article-title":"Validation of an electronic, population-based prescription database","volume":"32","author":"Kozyrskyj","year":"1998","journal-title":"Ann Pharmacother"},{"issue":"6","key":"2025073008263727300_ref26","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1002\/jbmr.3682","article-title":"Accuracy of FRAX(R) in people with multiple sclerosis","volume":"34","author":"Bisson","year":"2019","journal-title":"J Bone Miner Res"},{"issue":"8","key":"2025073008263727300_ref27","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1002\/jbmr.3726","article-title":"Performance of FRAX in women with breast cancer initiating aromatase inhibitor therapy: a registry-based cohort study","volume":"34","author":"Leslie","year":"2019","journal-title":"J Bone Miner Res"},{"issue":"5","key":"2025073008263727300_ref28","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1002\/jbmr.2734","article-title":"A meta-analysis of trabecular bone score in fracture risk prediction and its relationship to FRAX","volume":"31","author":"McCloskey","year":"2016","journal-title":"J Bone Miner Res"},{"issue":"3","key":"2025073008263727300_ref29","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1002\/jbmr.2063","article-title":"Bone loss after bariatric surgery: discordant results between DXA and QCT bone density","volume":"29","author":"Yu","year":"2014","journal-title":"J Bone Miner Res"},{"issue":"12","key":"2025073008263727300_ref30","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1002\/jbmr.3851","article-title":"Clinical performance of the updated trabecular bone score (TBS) algorithm, which accounts for the soft tissue thickness: the OsteoLaus study","volume":"34","author":"Shevroja","year":"2019","journal-title":"J Bone Miner Res"},{"issue":"24","key":"2025073008263727300_ref31","doi-asserted-by":"publisher","first-page":"2947","DOI":"10.1001\/jama.296.24.2947","article-title":"Long-term proton pump inhibitor therapy and risk of hip fracture","volume":"296","author":"Yang","year":"2006","journal-title":"JAMA"},{"issue":"8","key":"2025073008263727300_ref32","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1592\/phco.28.8.951","article-title":"Proton pump inhibitor use and risk of hip fractures in patients without major risk factors","volume":"28","author":"Kaye","year":"2008","journal-title":"Pharmacotherapy"},{"issue":"12","key":"2025073008263727300_ref33","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1007\/s00198-009-0891-4","article-title":"Fracture risk in patients receiving acid-suppressant medication alone and in combination with bisphosphonates","volume":"20","author":"De Vries","year":"2009","journal-title":"Osteoporos Int"},{"issue":"1","key":"2025073008263727300_ref34","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1053\/j.gastro.2010.03.055","article-title":"Proton pump inhibitors and histamine-2 receptor antagonists are associated with hip fractures among at-risk patients","volume":"139","author":"Corley","year":"2010","journal-title":"Gastroenterology"},{"issue":"6","key":"2025073008263727300_ref35","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1517\/14740338.2011.586628","article-title":"The relationship among proton pump inhibitors, bone disease and fracture","volume":"10","author":"Targownik","year":"2011","journal-title":"Expert Opin Drug Saf"},{"issue":"4","key":"2025073008263727300_ref36","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s00223-008-9170-1","article-title":"Acid-suppressive medications and risk of bone loss and fracture in older adults","volume":"83","author":"Yu","year":"2008","journal-title":"Calcif Tissue Int"},{"issue":"9","key":"2025073008263727300_ref37","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1001\/archinternmed.2010.94","article-title":"Proton pump inhibitor use, hip fracture, and change in bone mineral density in postmenopausal women: results from the Women's Health Initiative","volume":"170","author":"Gray","year":"2010","journal-title":"Arch Intern Med"},{"issue":"3","key":"2025073008263727300_ref38","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1053\/j.gastro.2009.11.014","article-title":"Proton-pump inhibitor use is not associated with osteoporosis or accelerated bone mineral density loss","volume":"138","author":"Targownik","year":"2010","journal-title":"Gastroenterology"},{"issue":"9","key":"2025073008263727300_ref39","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1038\/ajg.2012.200","article-title":"The relationship between proton pump inhibitor use and longitudinal change in bone mineral density: a population-based from the Canadian Multicentre Osteoporosis Study (CaMos)","volume":"107","author":"Targownik","year":"2012","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"2025073008263727300_ref40","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1001\/jamainternmed.2013.2851","article-title":"Proton pump inhibitors and risk of 1-year mortality and rehospitalization in older patients discharged from acute care hospitals","volume":"173","author":"Maggio","year":"2013","journal-title":"JAMA Intern Med"},{"issue":"17","key":"2025073008263727300_ref41","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1001\/archinternmed.2010.304","article-title":"Use of proton pump inhibitors and mortality among institutionalized older people","volume":"170","author":"Bell","year":"2010","journal-title":"Arch Intern Med"},{"issue":"3","key":"2025073008263727300_ref42","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3109\/02813432.2010.493315","article-title":"Use of proton-pump inhibitors and their associated risks among frail elderly nursing home residents","volume":"28","author":"Teramura-Gr\u00f6nblad","year":"2010","journal-title":"Scand J Prim Health Care"},{"issue":"50","key":"2025073008263727300_ref43","doi-asserted-by":"publisher","first-page":"82055","DOI":"10.18632\/oncotarget.13255","article-title":"Abdominal adipose tissue thickness measured using magnetic resonance imaging is associated with lumbar disc degeneration in a Chinese patient population","volume":"7","author":"Yang","year":"2016","journal-title":"Oncotarget"},{"issue":"6","key":"2025073008263727300_ref44","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1007\/s00198-014-2685-6","article-title":"TBS result is not affected by lumbar spine osteoarthritis","volume":"25","author":"Kolta","year":"2014","journal-title":"Osteoporos Int"},{"issue":"1","key":"2025073008263727300_ref45","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s11657-018-0544-3","article-title":"Is trabecular bone score less affected by degenerative-changes at the spine than lumbar spine BMD?","volume":"13","author":"Anderson","year":"2018","journal-title":"Arch Osteoporos"},{"issue":"8","key":"2025073008263727300_ref46","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1007\/s00198-022-06407-w","article-title":"Effect of degeneration on bone mineral density, trabecular bone score and CT Hounsfield unit measurements in a spine surgery patient population","volume":"33","author":"Hayden","year":"2022","journal-title":"Osteoporos Int"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jbmr\/advance-article-pdf\/doi\/10.1093\/jbmr\/zjaf072\/63181814\/zjaf072.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/40\/8\/965\/63181814\/zjaf072.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/40\/8\/965\/63181814\/zjaf072.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T12:26:44Z","timestamp":1753878404000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/40\/8\/965\/8131598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,14]]},"references-count":46,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,5,14]]},"published-print":{"date-parts":[[2025,7,28]]}},"URL":"https:\/\/doi.org\/10.1093\/jbmr\/zjaf072","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,8]]},"published":{"date-parts":[[2025,5,14]]}}}